|

BMD006 in combination with PD-1 antibody Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Lung Metastasis1
  • Advanced Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.